Shukra Pharmaceuticals Limited reported earnings results for the fourth quarter ended March 31, 2023. For the fourth quarter, the company reported sales was INR 462.46 million compared to INR 89.36 million a year ago. Revenue was INR 471.37 million compared to INR 89.73 million a year ago.

Net income was INR 39.77 million compared to INR 6.47 million a year ago. Basic earnings per share from continuing operations was INR 5.865 compared to INR 1.0325 a year ago. Diluted earnings per share from continuing operations was INR 5.865 compared to INR 1.0325 a year ago.